|
1
|
McDougal W, Wein A, Kavoussi L, Novick A,
Partin A, Peters C and Ramchandani P: Malignant renal tumors. In:
Campbell-walsh Urology 10th Edition Review. Elsevier Health
Sciences. 14362011.
|
|
2
|
Andola SK, Laheru V and Patil S:
Collecting duct carcinoma of the kidney. J Sci Res. 6:46–48.
2013.
|
|
3
|
Méjean A, Rouprêt M, Larousserie F,
Hopirtean V, Thiounn N and Dufour B: Is there a place for radical
nephrectomy in the presence of metastatic collecting duct (Bellini)
carcinoma? J Urol. 169:1287–1290. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Peyromaure M, Thiounn N, Scotté F,
Vieillefond A, Debré B and Oudard S: Collecting duct carcinoma of
the kidney: A clinicopathological study of 9 cases. J Urol.
170:1138–1140. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tokuda N, Naito S, Matsuzaki O, Nagashima
Y, Ozono S and Igarashi T; Japanese Society of Renal Cancer:
Collecting duct (Bellini duct) renal cell carcinoma: A nationwide
survey in Japan. J Urol. 176:40–43. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Oudard S, Banu E, Vieillefond A, Fournier
L, Priou F, Medioni J, Banu A, Duclos B, Rolland F, Escudier B, et
al: Prospective multicenter phase II study of gemcitabine plus
platinum salt for metastatic collecting duct carcinoma: Results of
a GETUG (Groupe d'Etudes des Tumeurs Uro-Génitales) study. J Urol.
177:1698–1702. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dason S, Allard C, Sheridan-Jonah A, Gill
J, Jamshaid H, Aziz T, Kajal B and Kapoor A: Management of renal
collecting duct carcinoma: A systematic review and the McMaster
experience. Curr Oncol. 20:e223–e232. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Barrascout E, Beuselinck B, Ayllon J,
Bättig B, Moch H, Teghom C and Oudard S: Complete remission of
pulmonary metastases of Bellini duct carcinoma with cisplatin,
gemcitabine and bevacizumab. Am J Case Rep. 13:1–2. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pécuchet N, Bigot F, Gachet J, Massard C,
Albiges L, Teghom C, Allory Y, Méjean A, Escudier B and Oudard S:
Triple combination of bevacizumab, gemcitabine and platinum salt in
metastatic collecting duct carcinoma. Ann Oncol. 24:2963–2967.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mennitto A, Verzoni E, Peverelli G, Alessi
A and Procopio G: Management of metastatic collecting duct
carcinoma: An encouraging result in a patient treated with
cabozantinib. Clin Genitourin Cancer. 16:e521–e523. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Selli C, Amorosi A, Vona G, Sestini R,
Tmvaglini F, Bartoletti R and Orlando C: Retrospective evaluation
of c-erbb-2 oncogene amplification using competitive PCR in
collecting duct carcinoma of the kidney. J Urol. 158:245–247. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bronchud MH, Castillo S, Escriva de Romaní
S, Mourelo S, Fernández A, Baena C, Murillo J, Julia JC, Esquius J,
Romero R and Andreu X: HER2 blockade in metastatic collecting duct
carcinoma (CDC) of the kidney: A case report. Onkologie.
35:776–779. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Procopio G, Verzoni E, Iacovelli R,
Colecchia M, Torelli T and Mariani L: Is there a role for targeted
therapies in the collecting ducts of Bellini carcinoma? Efficacy
data from a retrospective analysis of 7 cases. Clin Exp Nephrol.
16:464–467. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Koshkin VS, Barata PC, Zhang T, George DJ,
Atkins MB, Kelly WJ, Vogelzang NJ, Pal SK, Hsu J, Appleman LJ, et
al: Clinical activity of nivolumab in patients with non-clear cell
renal cell carcinoma. J Immunother Cancer. 6:92018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mizutani K, Horie K, Nagai S, Tsuchiya T,
Saigo C, Kobayashi K, Miyazaki T and Deguchi T: Response to
nivolumab in metastatic collecting duct carcinoma expressing PD-L1:
A case report. Mol Clin Oncol. 7:988–990. 2017.PubMed/NCBI
|
|
16
|
Malouf GG, Compérat E, Yao H, Mouawad R,
Lindner V, Rioux-Leclercq N, Verkarre V, Leroy X, Dainese L, Classe
M, et al: Unique transcriptomic profile of collecting duct
carcinomas relative to upper tract urothelial carcinomas and other
kidney carcinomas. Sci Rep. 6:309882016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pal SK, Choueiri TK, Wang K, Khaira D,
Karam JA, Van Allen E, Palma NA, Stein MN, Johnson A, Squillace R,
et al: Characterization of clinical cases of collecting duct
carcinoma of the kidney assessed by comprehensive genomic
profiling. Eur Urol. 70:516–521. 2016. View Article : Google Scholar : PubMed/NCBI
|
